| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer JS Miller, Y Soignier, A Panoskaltsis-Mortari, SA McNearney, GH Yun, ... Blood 105 (8), 3051-3057, 2005 | 2077 | 2005 |
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation NS Majhail, JD Rizzo, SJ Lee, M Aljurf, Y Atsuta, C Bonfim, LJ Burns, ... Hematology/oncology and stem cell therapy 5 (1), 1-30, 2012 | 766 | 2012 |
| Williams hematology MA Lichtman McGraw-Hill, 2006 | 644 | 2006 |
| Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems ML MacMillan, DJ Weisdorf, JE Wagner, TE DeFor, LJ Burns, ... Biology of blood and marrow transplantation 8 (7), 387-394, 2002 | 499 | 2002 |
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and … JD Rizzo, JR Wingard, A Tichelli, SJ Lee, MT Van Lint, LJ Burns, ... Biology of Blood and Marrow Transplantation 12 (2), 138-151, 2006 | 452 | 2006 |
| Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma K Van Besien, FR Loberiza Jr, R Bajorunaite, JO Armitage, A Bashey, ... Blood 102 (10), 3521-3529, 2003 | 447 | 2003 |
| Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study K Scott Baker, KK Ness, J Steinberger, A Carter, L Francisco, LJ Burns, ... Blood 109 (4), 1765-1772, 2007 | 420 | 2007 |
| New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors KS Baker, TE DeFor, LJ Burns, NKC Ramsay, JP Neglia, LL Robison Journal of Clinical Oncology 21 (7), 1352-1358, 2003 | 371 | 2003 |
| IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial LJ Burns, DJ Weisdorf, TE DeFor, DH Vesole, TL Repka, BR Blazar, ... Bone marrow transplantation 32 (2), 177-186, 2003 | 314 | 2003 |
| Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu S Cooley, LJ Burns, T Repka, JS Miller Experimental hematology 27 (10), 1533-1541, 1999 | 304 | 1999 |
| Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR J Dehn, S Spellman, CK Hurley, BE Shaw, JN Barker, LJ Burns, ... Blood, The Journal of the American Society of Hematology 134 (12), 924-934, 2019 | 273 | 2019 |
| Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma SM Smith, LJ Burns, K van Besien, J LeRademacher, W He, TS Fenske, ... Journal of clinical oncology 31 (25), 3100-3109, 2013 | 267 | 2013 |
| Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin’s lymphoma NS Majhail, DJ Weisdorf, TE Defor, JS Miller, PB McGlave, A Slungaard, ... Biology of Blood and Marrow Transplantation 12 (10), 1065-1072, 2006 | 244 | 2006 |
| Allogeneic natural killer cells for refractory lymphoma V Bachanova, LJ Burns, DH McKenna, J Curtsinger, ... Cancer immunology, immunotherapy 59, 1739-1744, 2010 | 207 | 2010 |
| Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning P Hari, J Carreras, MJ Zhang, RP Gale, BJ Bolwell, CN Bredeson, ... Biology of blood and marrow transplantation 14 (2), 236-245, 2008 | 197 | 2008 |
| Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell … JM Vose, S Carter, LJ Burns, E Ayala, OW Press, CH Moskowitz, ... Journal of Clinical Oncology 31 (13), 1662-1668, 2013 | 193 | 2013 |
| Burnout, moral distress, work–life balance, and career satisfaction among hematopoietic cell transplantation professionals JL Neumann, LW Mau, S Virani, EM Denzen, DA Boyle, NJ Boyle, ... Biology of Blood and Marrow Transplantation 24 (4), 849-860, 2018 | 192 | 2018 |
| Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation KM Williams, GS Cheng, I Pusic, M Jagasia, L Burns, VT Ho, J Pidala, ... Biology of Blood and Marrow Transplantation 22 (4), 710-716, 2016 | 190 | 2016 |
| High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation NS Majhail, ME Flowers, KK Ness, M Jagasia, PA Carpenter, M Arora, ... Bone marrow transplantation 43 (1), 49-54, 2009 | 179 | 2009 |
| Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American … T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ... Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019 | 176 | 2019 |
